Drug Shortage Report for BETOPTIC S
Report ID | 115462 |
Drug Identification Number | 01908448 |
Brand name | BETOPTIC S |
Common or Proper name | BETOPTIC 0.25% SUSP. 5ML |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | BETAXOLOL |
Strength(s) | 0.25% |
Dosage form(s) | SUSPENSION |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 5ML |
ATC code | S01ED |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2020-06-26 |
Actual start date | 2020-06-29 |
Estimated end date | 2020-08-26 |
Actual end date | 2020-08-27 |
Shortage status | Resolved |
Updated date | 2020-08-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v14 | 2020-08-28 | English | Compare |
v13 | 2020-08-27 | French | Compare |
v12 | 2020-08-27 | English | Compare |
v11 | 2020-08-27 | English | Compare |
v10 | 2020-06-30 | English | Compare |
v9 | 2020-06-29 | French | Compare |
v8 | 2020-06-29 | English | Compare |
v7 | 2020-06-27 | English | Compare |
v6 | 2020-06-05 | French | Compare |
v5 | 2020-06-05 | English | Compare |
v4 | 2020-06-04 | English | Compare |
v3 | 2020-05-21 | French | Compare |
v2 | 2020-05-21 | English | Compare |
v1 | 2020-05-21 | English | Compare |
Showing 1 to 14 of 14